• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Cancer Organoids Offer Insights into Treatment Outcomes

      Cancer Organoids Offer Insights into Treatment Outcomes

      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Laser-Based Breath Analysis Detects COVID-19 Infection

      Laser-Based Breath Analysis Detects COVID-19 Infection

      Technique Reveals 3D Genome Interactions

      Technique Reveals 3D Genome Interactions

    • Radiology
      Implanted Ultrasound Lets Chemo Access Brain

      Implanted Ultrasound Lets Chemo Access Brain

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

    • Cardiology
      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Chest Wearable Provides Key Heart Measurements

      Chest Wearable Provides Key Heart Measurements

      Vein on a Chip Includes Flexible Valves

      Vein on a Chip Includes Flexible Valves

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

    • Surgery
      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Stimulating Wounds with Electricity for Rapid Healing

      Stimulating Wounds with Electricity for Rapid Healing

    • Nanomedicine
      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Global Pulmonary Arterial Hypertension (PAH) Market Size Is Projected to Reach US$ 9.78 Billion at a CAGR of 5.9% By 2027 | Share Analysis, Future Growth Insights, Application, Global Healthcare Products Industry Trends

January 16th, 2020 Coherent Market Insights Releases

According to Coherent Market Insights, global pulmonary arterial hypertension (PAH) market was valued at US$ 5,821.90 million in 2018 and is expected to exhibit a CAGR of 5.9% over the forecast period (2019-2027).

Key Trends and Analysis of the Pulmonary Arterial Hypertension (PAH) Market:

Key trends in the market include rising cases of chronic lung diseases and increasing product approvals and launches coupled with novel development of treatment of pulmonary arterial hypertension (PAH) by players, which is expected to propel the market growth over the forecast period.

Request Free PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/203

Increasing cases of pulmonary arterial hypertension (PAH) is expected to boost growth of the market over the forecast period. For instance, according to the National Organization for Rare Disorder (NORD), 2018, around 500 to 1,000 new cases of pulmonary arterial hypertension are diagnosed each year in the U.S.

Moreover, various mergers, agreements, and acquisitions by key players are expected to propel the market growth. For instance, in January 2017, Acetlion announced that Johnson & Johnson acquired shares of Actelion for US$ 280 per share. This definitive transaction agreement expected to accelerate Johnson & Johnson’s revenue and earnings growth rates. This acquisition took place, as Actelion had established a franchise of differentiated & innovative products for treating pulmonary arterial hypertension (PAH), which was complementary to the existing portfolio of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Furthermore, increasing number of players are focusing on developing innovative drugs, in order to fulfill the unmet need in the market, which is expected to drive the market growth over the forecast period. For instance, in 2018, according to the National Institute of Health, around 15 clinical trials involving Iloprost were active globally. For instance, in November 2015, the National Cancer Institute initiated a phase I clinical trial for evaluating iloprost in preventing recurrence of lung cancer for patients who smoke and the study is expected to complete in 2020.

Browse Press Release: https://www.coherentmarketinsights.com/press-release/pulmonary-arterial-hypertension-pah-market-2691

However, stringent regulations for drugs are expected to restrain the market growth over the forecast period. For instance, according to the Congressional Research Service, article published in May 2018, reports that the Food and Drug Administration (FDA), a regulatory agency within the Department of Health and Human Services, regulates the safety and effectiveness of any novel drugs that is approved or launched or sold in the U.S. FDA approves in the two phases, preapproval (premarket) phase, and postapproval (postmarket) phase. For processing a novel drug, the company or manufacturer must seek and receive FDA approval through investigational new drug (IND) application. If approved by FDA, it leads to Clinical Trials, which comprises of Phase I, II, III & IV. Then the manufacturer then compiles the resulting data and analysis in a new drug application (NDA). FDA reviews the NDA through the Federal Food, Drug, and Cosmetic Act (FFDCA) in detail for safety & efficacy with the drugs’ identity, strength, quality, and purity. Once FDA has approved an NDA, the drug may enter the U.S. market, but FDA continues to address drug production, distribution, and use. All these above steps take 10-12 years to launch a drug in the market.

Key Market Takeaways:

  • The global pulmonary arterial hypertension (PAH) market is expected to exhibit a CAGR of 5.9% over the forecast period (2019-2027) due to rising prevalence of heart problems leading to pulmonary arterial hypertension. For instance, according to the American Heart Association, Inc., globally heart failures are the most common cause of the pulmonary arterial hypertension (PAH). Moreover, according to the Centers for Disease Control and Prevention (CDC), a report- Heart disease and stroke statistics-2019, from the American Heart Association states that around 6.5 million adults in the U.S. suffered from heart failure.
  • Key players in the market are focused on developing new products with improved clinical outcomes to enhance their product portfolio, which is expected to propel the market growth over the forecast period. For instance, in October 2019, Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson Services Inc., released new data evaluating initial combination therapy with OPSUMIT (macitentan) and tadalafIl, a PDE5 inhibitor studied on patients with pulmonary arterial hypertension (PAH). This combination showed hemodynamic improvement, as well as improvements in functional parameters.
  • Key players operating in the global pulmonary arterial hypertension (PAH) market include United Therapeutics Corporation, GlaxoSmithKline plc, Novartis AG, AstraZeneca, Bayer AG, Merck KGaA, Pfizer Inc., Gilead Sciences, Inc., Actelion Pharmaceuticals Ltd, Arena Pharmaceuticals, and Daiichi Sankyo Company, Limited.

Purchase a copy of Pulmonary Arterial Hypertension PAH Market Report: https://www.coherentmarketinsights.com/insight/buy-now/203

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Media Contact:

Name: Mr. Raj Shah
Email: sales@coherentmarketinsights.com
Phone: US +12067016702
Country: United States
Website: https://www.coherentmarketinsights.com/
Visit Blog: https://globalindustryresearchblog.wordpress.com/

Sign up and submit a press release

Sponsored

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

Novel Approach to Assessing Lung Function Enables Improved Detection, Diagnosis and Treatment Decisions in Subject Exposed to Military Burn Pits

U.S. Patent Office Grants Additional Patent Protection For  Exoskeleton Focal-Force Angioplasty Platform

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

interviews & reviews
Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email